Literature DB >> 32918996

Brazilian red propolis exhibits antiparasitic properties in vitro and reduces worm burden and egg production in an mouse model harboring either early or chronic Schistosoma mansoni infection.

Marcos P Silva1, Thiago M Silva2, Ana C Mengarda3, Maria C Salvadori4, Fernanda S Teixeira5, Severino M Alencar6, Givelton C Luz Filho7, Bruno Bueno-Silva8, Josué de Moraes1.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Propolis has been used in folk medicine for thousands of years and, in the past few decades, it has attracted renewed interest. Although propolis has been traditionally used in many communities worldwide against parasitic diseases, its effect against Schistosoma mansoni infection remains unclear. AIM OF THE STUDY: To demonstrate the effects of Brazilian red propolis on Schistosoma mansoni ex vivo and in an animal model of schistosomiasis.
MATERIALS AND METHODS: In vitro, we monitored phenotypic and tegumental changes as well as the effects of the crude extract of propolis on pairing and egg production. In a mouse infected with either immature (early infection) or adult (chronic infection) worms, propolis was administered by oral gavage and we studied the influence of this natural product on worm burden and egg production.
RESULTS: Propolis 25 μg/mL reduced motility and caused 100% mortality of adult parasites ex vivo. Further analysis revealed a pronounced reduction in oviposition after exposure to propolis at sub-lethal concentrations. In addition, scanning electron microscopy showed morphological alterations in the tegument of schistosomes. In the animal model, propolis markedly reduced worm burden and egg production in both early and chronic S. mansoni infection when compared to untreated control animals.
CONCLUSIONS: The efficacy of Brazilian red propolis in both in vitro and in vivo studies suggests its potential anthelmintic properties against S. mansoni infection.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anthelmintic; Natural products; Propolis; Schistosoma; Schistosomiasis; Schistosomicidal activity

Mesh:

Substances:

Year:  2020        PMID: 32918996     DOI: 10.1016/j.jep.2020.113387

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  7 in total

1.  Therapeutic Efficacy of Carvacrol-Loaded Nanoemulsion in a Mouse Model of Schistosomiasis.

Authors:  Edilaine S Xavier; Rafael L de Souza; Vinícius C Rodrigues; Camila O Melo; Daniel B Roquini; Bruna L Lemes; Polrat Wilairatana; Elquio E Oliveira; Josué de Moraes
Journal:  Front Pharmacol       Date:  2022-06-17       Impact factor: 5.988

2.  Brazilian green propolis reduces worm burden and hepatic granuloma formation in a Schistosoma mansoni experimental murine model.

Authors:  Lucas A de L Paula; Mário F C Santos; Mariana C Pagotti; Rodrigo C S Veneziani; Jairo K Bastos; Conor R Caffrey; Sérgio R Ambrósio; Lizandra G Magalhães
Journal:  Parasitol Res       Date:  2022-01-20       Impact factor: 2.289

Review 3.  An Overview of the Evidence and Mechanism of Drug-Herb Interactions Between Propolis and Pharmaceutical Drugs.

Authors:  Sanowar Hossain; Muhammad Yousaf; Yang Liu; Dennis Chang; Xian Zhou
Journal:  Front Pharmacol       Date:  2022-04-04       Impact factor: 5.988

Review 4.  Propolis from the Monte Region in Argentina: A Potential Phytotherapic and Food Functional Ingredient.

Authors:  Iris Catiana Zampini; Ana Lia Salas; Luis M Maldonado; Mario J Simirgiotis; María Inés Isla
Journal:  Metabolites       Date:  2021-01-28

Review 5.  Antifungal Properties of Chemically Defined Propolis from Various Geographical Regions.

Authors:  Marcin Ożarowski; Tomasz M Karpiński; Rahat Alam; Małgorzata Łochyńska
Journal:  Microorganisms       Date:  2022-02-04

6.  In Vitro Cercaricidal and Schistosomicidal Activities of the Raffia Wine and Hydroethanolic Extracts of Pedilanthus tithymaloides Linn (Poit). Stem Barks.

Authors:  Emilienne Tienga Nkondo; Hermine Boukeng Jatsa; Nestor Gipwe Feussom; Mérimé Christian Kenfack; Ulrich Membe Femoe; Stephanie Tamdem Guetchueng; Theodora Kopa Kowa; Pierre Kamtchouing; Louis-Albert Tchuem Tchuente
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-16       Impact factor: 2.650

7.  Pyrazoline derivatives as promising novel antischistosomal agents.

Authors:  Cristiane S Morais; Ana C Mengarda; Fábio B Miguel; Karine B Enes; Vinícius C Rodrigues; Maria Cristina C Espírito-Santo; Abolghasem Siyadatpanah; Polrat Wilairatana; Mara R C Couri; Josué de Moraes
Journal:  Sci Rep       Date:  2021-12-06       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.